La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Micron Solutions a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Micron Solutions..

Micron Solutions (OTC:MICRD) Azioni, Catena delle Opzioni

Micron Solutions Inc is a diversified contract manufacturing organization that produces engineered medical device components requiring precision machining and injection molding. It provides design, engineering, quality, and regulatory expertise across the three product lines, machining, thermoplastic injection molding, and sensors. It's engaged in the production and sale of silver chloride-coated and conductive resin sensors used as consumable component parts in the manufacture of integrated disposable electrophysiological sensors. It also provides other value-added services, including the design, manufacture, and rehabilitation of injection molding tools, pad printing, ultrasonic welding, stamping, laser marking, clean room molding, and others.

MICRON SOLUTIONS INC NEW by Micron Solutions, Inc.

Micron Solutions Inc

<a href="https://www.globenewswire.com/Tracker?data=ge4uowfq6OhamqthR0uEfsT-MbXLFuTOiNKi2D3TO3dqXPEVesWvxHcX1V5KUgpjNQYjtnwkEKKOKUbXRA1MBw==">Datadog</a>, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDOG#NASDAQ">DDOG</a>), the monitoring and security platform for cloud applications, today announced it has acquired <a href="https://www.globenewswire.com/Tracker?data=EosvttSO_dUE5Tpsdlixi6sk8x3lwRZy5emK-njGFair2OHoajcQ6-inrMa5cGbTTm0SkGdhwUOco8UNIhyOKw==">Eppo</a>, a feature flagging and experimentation platform, which will tightly integrate with Datadog's existing Product Analytics suite.
Today,&nbsp;application developers need to stitch together analytics from various tools across engineering, product and business teams to understand the impact of their new features and improvements. Changes are often rolled out without understanding their impact to KPIs, making it difficult to tie these changes back to business outcomes.
With its acquisition of Eppo, Datadog creates a full end-to-end product analytics solution on one platform. This unified approach means that engineers can track code changes with feature flags, data science leaders together with product managers can design and measure impact with experiments, and business analysts can use Datadog's Product Analytics suite to understand overall product usage and business outcomes.
As AI workloads grow, Eppo's experimentation capabilities help developers safely scale complex systems. These capabilities can measure the impact to the overall user experience in real time and accelerate the safe roll-out of changes, ultimately creating a more agile and trustworthy development workflow.

DDOG

Datadog Acquires Eppo To Expand Its AI, Product Analytics, Experimentation And Feature Flag Capabilities; No Financial Terms Disclosed

As public curiosity around cannabis continues to surge, a new voice is stepping forward to provide clarity, backed by science, not hype.
Dr. Riley Kirk, a cannabis research scientist and popular TikTok educator known as <a href="https://www.tiktok.com/@cannabichem">@cannabichem</a>, will release her debut book, &#8220;Reefer Wellness: Understanding Cannabis Science, Culture, and Medicine,&#8221; this June.
The book aims to bridge the growing gap between legalization and consumer understanding. While more U.S. states have adopted regulated cannabis markets, many consumers still struggle with basic questions: What products are safe? How much should I take? Can cannabis actually help with sleep or pain?
&#8220;Reefer Wellness&#8221; addresses these concerns head-on, offering science-backed insights in an accessible format designed for both newcomers and experienced users.
<h3 class="wp-block-heading">Breaking Down Cannabis Without The Buzzwords</h3>
Rather than promoting consumption, Kirk's book focuses on how cannabis works in the body, especially through the endocannabinoid system (ECS), a key biological network that helps regulate pain, mood, appetite, and sleep. Readers can expect:
<ul>
<li>A visual introduction to how cannabinoids interact with ECS receptors</li>
<li>Detailed pros and cons of different consumption methods, from edibles to inhalation</li>
<li>Dosage guidance and practical tips for finding your personal therapeutic range</li>
<li>Evidence-based insights into cannabis use for chronic pain, anxiety and insomnia</li>
<li>Strategies for managing common side effects like dry mouth or increased appetite</li>
</ul>
In short, Kirk's book is less about selling weed and more about helping readers make informed decisions in a complex and often misunderstood space.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="606" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/03130856/Screen-Shot-2025-05-03-at-14.05.20-1024x606.png" alt="" class="wp-image-900247" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/03130856/Screen-Shot-2025-05-03-at-14.05.20-1024x606.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/03130856/Screen-Shot-2025-05-03-at-14.05.20-300x178.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/03130856/Screen-Shot-2025-05-03-at-14.05.20-768x454.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/03130856/Screen-Shot-2025-05-03-at-14.05.20-1536x909.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/03130856/Screen-Shot-2025-05-03-at-14.05.20.png 1592w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h3 class="wp-block-heading">A Scientist Who Speaks Your Language</h3>
Dr. Kirk holds a Ph.D. in Pharmaceutical Sciences from the University of Rhode Island, with a specialty in natural product chemistry, an area that includes plants, fungi and even cyanobacteria. Her academic work has been published in peer-reviewed journals, but her approachable online persona has made her one of the most visible science communicators in the cannabis space.
On TikTok, where she's amassed over 475,000 followers, Kirk posts engaging videos that blend serious pharmacology with relatable humor. Her goal: to destigmatize cannabis and promote informed use through education, not ideology.
Her upcoming book is a natural extension of that mission.
<h3 class="wp-block-heading">A Timely Resource In A Shifting Landscape</h3>
As federal cannabis reform remains uncertain and the industry continues to mature, there's a growing need for trusted voices that can cut through misinformation and marketing jargon. Kirk&#8217;s &#8220;Reefer Wellness&#8221; arrives at a moment when health-conscious consumers are searching for transparent, accurate, and balanced information about cannabis and its role in wellness.
Images courtesy of Dr. Riley Kirk

Cannabis

Education

Media

Cannabis Scientist-Turned-Influencer Dr. Riley Kirk (@cannabichem) To Release Book 'Reefer Wellness'

China and the U.S. appear ready to hit pause on tit-for-tat tariffs to pursue a potential trade agreement, inspiring Wall Street veteran investor Ed Yardeni to <a href="https://www.benzinga.com/topic/recession">dial back recession odds</a>. 
What Happened: Signs emerge that Washington, D.C. and Beijing may finally be willing to ease trade tensions that have rocked global markets <a href="https://www.benzinga.com/news/econ-s">and dented economic confidence.</a>
In a note shared Monday, Yardeni said he's reducing his subjective probability of a U.S. recession to 35%. That&#8217;s down from 45% at the end of March.
Yardeni&#8217;s new estimate matches the level seen in early March and reflects growing optimism that ongoing tariff disputes will de-escalate.
"We are now lowering our odds of a recession back down to 35% because we believe that China and the US both may be ready to suspend their tariffs on each other while they negotiate a trade deal," the Yardeni Research President said.
"In other words, both sides may be starting to blink."
Markets have been rebounding sharply amid latest trade developments. Yardeni sees this as a reflection of confidence in a resolution and perhaps an early end to what he dubbed Trump's &#8220;Reign of Tariffs.&#8221;
Yet, he isn't blind to risks. 
"There could still be supply disruptions resulting from the still unresolved trade war with China," he said, noting that regional and national business surveys have indicated softening economic activity and rising prices through March and April.
CFTC-regulated prediction market Kalshi shows recession odds — defined as two consecutive quarters of negative gross domestic product — have fallen from 69% a week ago to 55% as of early May. When Donald Trump was sworn in as the 47th U.S. president, odds were just 19%.
Why It Matters: Despite the softening probability, Yardeni still considers the current economic environment fragile, citing heavy consumer exposure to financial markets.
"We had been concerned recently about the negative wealth effect on consumption because of the drop in stock prices," Yardeni said, but recent gains in equity markets have alleviated that concern.
The S&amp;P 500 — as tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) — rallied sharply in April. Yardeni is weighing whether to revise his year-end target higher again.
He initially forecasted 7,000 for 2025 but lowered that to 6,400 on March 5 and then to 6,000 by March 31.
"We are inclined to do so given the power of the V-shaped rally in the S&amp;P 500," Yardeni said. "However, we aren't ready to do so" due to ongoing earnings pressure and valuation concerns.
On April 8, the price-to-earnings multiple for the index bottomed at 18.1 but rose to 20.5 by the end of April. 
The biggest drag on earnings may still be tariffs, which Yardeni emphasized are "first and foremost taxes on domestic importers." 
Currently, the U.S. has imposed a 10% tariff on most imports, plus a 25% tariff on autos, aluminum and steel. Chinese goods have a staggering 145% levy.
What&#8217;s Next: With corporate tax receipts totaling $502.19 billion over the past 12 months, Yardeni estimates tariffs could raise over $300 billion in duties in the coming year — a significant potential hit to corporate profits unless companies pass costs on to consumers.
"Trump needs to put the trade issue behind him to reduce the odds of a recession, which would harm the Republicans' chances of holding onto their slim majorities in both houses of Congress," Yardeni said.
Court challenges to Trump's authority to impose tariffs under a national emergency declaration are also gaining traction. If the courts or political pressure force Trump to delay or drop the tariffs, Yardeni predicts it could trigger "a V-shaped stock-market bottom."
In his words: "We're counting on that; the alternative is just plain ugly."
Now Read: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/05/45188125/sp-500-notches-longest-win-streak-in-over-2-decades-investor-sentiment-improves-greed-index-in-fear-zone">S&amp;P 500 Notches Longest Win Streak In Over 2 Decades: Investor Sentiment Improves, Greed Index In &#8216;Fear&#8217; Zone</a></li>
</ul>
Image: Shutterstock

Analyst Color

Macro Economic Events

Broad U.S. Equity ETFs

Econ #s

Economics

Analyst Ratings

ETFs

Wall Street Veteran Investor Lowers Recession Risk As US-China Trade War Cools

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

Christian Thompson, Managing Director of the Sui Foundation, stated that bipartisan <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45187736/elizabeth-warren-slams-shady-deal-involving-trump-family-backed-usd1-as-democrats-withdraw-support-for-senarte-crypto-bill">U.S. stablecoin legislation</a> will be a powerful mechanism for driving capital formation and retail onboarding into Web3 ecosystems.
Speaking with Benzinga on the sidelines of Sui basecamp in Dubai, Thompson, a former Meta Deputy Chief Information Security Officer and Libra/Diem project contributor, emphasized stablecoins' role in enabling fast, inexpensive, and reliable cross-border transactions.
"It's a powerful method to bring people into Web3 and all the benefits that it has," Thompson said, highlighting stablecoins' ability to break down barriers between brokers and makers across countries, particularly in developing nations. 
"Anytime you're sending money between two people from one place to another, it's super fast, super reliable, [and] very inexpensive to do," he noted. 
This efficiency, he argued, makes stablecoins a critical tool for global commerce and financial inclusion.
Thompson's comments come as the U.S. Senate prepares to vote on the <a href="https://www.benzinga.com/content/44516699/u-s-congress-advances-stablecoin-regulation-with-the-introduction-of-the-stable-act">GENIUS Act</a> by May 26, which restricts stablecoin issuance to permitted issuers and requires 1:1 reserve backing with short-term Treasury securities.
The House is advancing the companion STABLE Act, with both bills gaining bipartisan support to establish a federal regulatory framework for stablecoins.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45132056/tether-ceo-says-big-four-accounting-firms-have-reversed-stance-now-pursuing-audit-talks">Tether CEO Says Big Four Accounting Firms Have Reversed Stance, Now Pursuing Audit Talks</a>
Drawing on his experience at Meta, Thompson sought to highlight the Sui Foundation's focus on security and scalability.
"Security is embedded in everything that we've built," he said, noting that three of the foundation's five co-founders have security backgrounds, ensuring robust protections for Web3 applications. 
He also highlighted Sui's technological advancements, such as the Walrus decentralized storage solution and the upcoming Seal primitive for access control, as key to supporting institutional and retail adoption.
Thompson predicted a "watershed moment" for real-world asset (RWA) tokenization, driven by regulatory clarity. 
He cited stablecoins' potential to enhance transparency in sectors like real estate, where tokenized titles could reduce ambiguity. 
"You get whole new asset classes that become available through RWA," he said, emphasizing the need for public understanding to accelerate adoption.
Addressing broader Web3 trends, Thompson expressed confidence in Sui's ability to deliver real value to businesses and users. 
He noted the foundation's work on zero-knowledge (ZK) login, which allows users to access Web3 services using Google or Apple IDs without sharing personal data, streamlining user experience. 
"ZK Login is the solution ultimately," he said, as it mirrors familiar Web2 authentication methods, fostering mainstream adoption.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45128841/crypto-wallet-fragmentation-grows-62-of-users-manage-multiple-wallets-report-says">Crypto Wallet Fragmentation Grows: 62% Of Users Manage Multiple Wallets, Report Says</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

US Stablecoin Legislation Will Transform Crypto, Says Sui Foundation's Christian Thompson

WIIM

Nexalin Technology shares are trading lower after the company announced a $5 million public offering.

BMO Capital analyst Rufus Hone downgrades Block (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>) from Outperform to Market Perform and lowers the price target from $80 to $58.

Downgrades

Price Target

BMO Capital Downgrades Block to Market Perform, Lowers Price Target to $58

AIFF

Firefly Neuroscience shares are trading higher after the company announced it acquired Evoke Neuroscience for $6 million in a cash-and-stock deal.

GPUS

Hyperscale Data shares are trading higher after the company issued Q1 and FY25 sales guidance.

Skechers shares are trading higher after the company agreed to be acquired by 3G Capital for $63 per share.

BMO Capital analyst Kevin O'Halloran downgrades Hecla Mining (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HL#NYSE">HL</a>) from Outperform to Market Perform and lowers the price target from $7.5 to $5.5.

BMO Capital Downgrades Hecla Mining to Market Perform, Lowers Price Target to $5.5

NSSC

NAPCO Security Technologies shares are trading higher after the company reported better-than-expected Q1 financial results.

<ul>
<li>Skechers will continue to be led by Chairman and Chief Executive Officer Robert Greenberg, President Michael Greenberg, and Chief Operating Officer David Weinberg</li>
<li>The Company will remain focused on its successful strategy of delivering style, comfort, quality, and innovation at an affordable price</li>
<li>Skechers and 3G Capital have a shared vision for the long-term future growth of the business</li>
<li>3G Capital to pay $63.00 per share in cash for Skechers, representing a premium of 30% to the Company's 15-day volume-weighted average stock price</li>
<li>3G Capital to offer all existing Skechers stockholders an alternative mixed consideration option</li>
<li>Skechers to become a privately held company upon completion of the transaction</li>
</ul>
Skechers U.S.A., Inc. ("Skechers" or the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKX#NYSE">SKX</a>), a Fortune 500 company and the third largest footwear company in the world, today announced that it has agreed to be acquired by 3G Capital, a global investment firm built on an owner-operator approach to long-term investing.
This press release features multimedia. View the full release here: <a href="https://www.businesswire.com/news/home/20250505432130/en/">https://www.businesswire.com/news/home/20250505432130/en/</a>
One of the largest founder-led consumer product companies in the world with $9 billion in annual sales, Skechers' significant growth over the past 30 years has been driven by a relentless focus on delivering style, comfort, quality, and innovation at an affordable price. Known as the Comfort Technology Company&#xAE;, Skechers is a growth-oriented, product-driven brand with a diverse distribution network, and highly loyal customers and consumers.

Skechers Agrees To Be Acquired By 3G Capital For $63.00 Per Share In Cash

BCRX

BioCryst Pharmaceuticals shares are trading higher after the company reported a Q1 sales beat.

In a week dominated <a href="https://www.benzinga.com/earnings">by earnings buzz</a>, a seismic shift in the app economy flew under the radar: a federal court gutted Apple Inc's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) 27% commission on alternative in-app payments &#8211; handing Epic a big win and developers a rare moment of leverage.
JPMorgan analyst Cory A. Carpenter says the ruling didn't get nearly the attention it deserved.
Read Also: <a href="https://www.benzinga.com/markets/25/05/45185355/apple-braces-for-900-million-tariff-impact-tim-cook-discusses-potential-iphone-manufacturing-shift-to-us-with-lutnick-and-more-this-week-in-appleverse">Apple Braces For $900 Million Tariff Impact, Tim Cook Discusses Potential iPhone Manufacturing Shift To US With Lutnick And More: This Week In Appleverse</a>
<h2 class="wp-block-heading">Epic Gets The Last Laugh &#8211; For Now</h2>
After a multi-year legal saga, Apple's attempt to cling to commissions on external payments has unraveled. The latest ruling declares that Apple cannot charge a commission on alternative payments, effective immediately. That's already materialized in Spotify Technology SA's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) latest app update, which Carpenter notes was approved without commission fees.
Developers are expected to jump on the opportunity. We expect &#8220;developers to flood the app store with similar updates in the coming days," said Carpenter.
Apple is appealing the decision. But unlike before, it must comply in the meantime—developers have at least two months to implement zero-commission alternatives unless the Ninth Circuit grants a stay.
<h2 class="wp-block-heading">Google: The Chill Bystander</h2>
Meanwhile, "Google Play transactions are not impacted by this ruling." That's because Alphabet Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) Google already offers its "User Choice" billing in many countries, with slightly lower fees &#8211; 11% for subscriptions and 26% for in-app purchases.
Carpenter points out that "Google's subscription service fee of 15% is already half that of Apple's 30% service fee."
<h2 class="wp-block-heading">Margin Gains Incoming?</h2>
If the ruling holds, developers stand to benefit. Carpenter estimates annual margin boosts of:
<ul>
<li>Match Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTCH#NASDAQ">MTCH</a>)/Bumble Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bmbl#NASDAQ">BMBL</a>): 3–6%</li>
<li>Take-Two Interactive Software, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ttwo#NASDAQ">TTWO</a>): 1–2%</li>
<li>Electronic Arts Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EA#NASDAQ">EA</a>): ~0.5%</li>
<li>Playstudios Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/myps#NASDAQ">MYPS</a>): 3–7%</li>
</ul>
AppLovin Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) may also gain indirectly as developers redirect savings to user acquisition.
A decision on the stay could take two months. But for now, the power dynamic has shifted &#8211; if only temporarily.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/05/45189765/sp-rally-may-be-topping-out-dan-niles-warns-amid-demand-pull-in-economic-uncertainty-and-sell-the-news-risk">S&amp;P Rally May Be Topping Out, Dan Niles Warns, Amid Demand Pull-In, Economic Uncertainty, And &#8216;Sell The News&#8217; Risk</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Penny Stocks

Small Cap

Tech

Trading Ideas

AAPL

BMBL

GOOG

GOOGL

MTCH

MYPS

SPOT

TTWO

Apple's 27% Fee Cut Is Good News For Epic, App Developers, Google Remains Unaffected

Peabody Energy shares are trading higher after the company announced it had notified Anglo American of a Material Adverse Change (MAC) impacting its planned acquisition of steelmaking coal assets from Anglo.

Billionaire investor and Bridgewater founder Ray Dalio has issued a stark warning: don't confuse financial success with life success. In a short video posted to his YouTube channel, Dalio stressed that money should serve a purpose, not be the purpose.
What Happened: Dalio <a href="https://www.youtube.com/shorts/x-_nhVo_QJQ">explained</a> that while financial security is vital, "You want to have security for you and your family. You want to have choices"—it should never come at the expense of clarity about what is meaningful.
"There are people who get hung up on making money,z and they almost lose sight of the things themselves, and that&#8217;s a tragedy," he said. He encouraged viewers to clarify what "the best life possible" means to them first.
See Also: <a href="https://www.benzinga.com/personal-finance/25/01/43166526/billionaire-warren-buffetts-first-wife-said-he-cared-about-the-win-not-the-money-its-all-mental-with-him-and-money-is-his-scorecard">Steve Jobs Warned The Difference Between Good And Great Software Engineers Is &#8217;50‑To‑1,&#8217; Admitted Firing Non-Performers Was &#8216;Very Painful&#8217; Yet Necessary</a>
Why It Matters: Dalio's comments offer a distinct perspective on hustle culture and wealth obsession. "If you have the best life possible and it&#8217;s some clarity as to what that is and you&#8217;re using money to help get there, that&#8217;s terrific… but don't make money itself the goal," he said.
Former Vice Chairman of Berkshire Hathaway <a href="https://www.benzinga.com/personal-finance/25/03/44146342/charlie-munger-said-he-was-passionate-about-getting-rich-but-not-because-i-wanted-ferraris-i-wanted-the-independence">Charlie Munger had previously shared a similar philosophy</a>, saying in 2003, &#8220;Like Warren [Buffett], I had a considerable passion to get rich. Not because I wanted Ferraris – I wanted the independence. I desperately wanted it.&#8221;
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/05/45185460/elon-musk-reacts-after-ray-dalio-warns-of-us-decline-us-retailers-push-chinese-suppliers-to-resume-shipments-and-more-this-week-in-economics">Elon Musk Reacts After Ray Dalio Warns Of US Decline, US Retailers Push Chinese Suppliers To Resume Shipments And More: This Week In Economics</a></li>
</ul>
Photo courtesy: T. Schneider / Shutterstock.com

Personal Finance

Ray Dalio Says Chasing Wealth Without Purpose Is A Tragedy: 'Don't Make Money Itself The Goal'

Company continues to expand global IP coverage and claims to major markets, now extending to June 2040&nbsp;
HOUSTON, May 05, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBRX#NASDAQ">MBRX</a>) ("Moleculin" or the "Company"), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat cancers and viruses, today announced the U.S. Patent and Trademark Office (USPTO) has granted two additional U.S. patents with claims covering Annamycin.&nbsp;U.S. patent number 12,257,261 titled, "Preparation of Preliposomal Annamycin Lyophilizate", has claims covering methods of making liposomal Annamycin and U.S. patent 12,257,262 titled "Method of Reconstituting Liposomal Annamycin", has claims covering methods of making liposomal Annamycin suspension.&nbsp;Both patents have a base patent term currently extending until June 2040, subject to adjustment for delays in prosecution and extension to account for time required to fulfill requirements for regulatory approval. Moleculin has additional patent applications related to Annamycin pending in the U.S., Europe and in major jurisdictions worldwide.

MBRX

Moleculin Secures Two New U.S. Patents for Annamycin, Expanding IP Portfolio Through 2040

OCUL

Ocular Therapeutix shares are trading lower after the company reported worse-than-expected Q1 financial results.

Susquehanna analyst Shyam Patil maintains trivago (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVG#NASDAQ">TRVG</a>) with a Neutral and raises the price target from $3.5 to $5.5.

TRVG

Susquehanna Maintains Neutral on trivago, Raises Price Target to $5.5

Micron Solutions

Comments

Micron Solutions

Micron Solutions (MICRD) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO